Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 2, 2005, Pages 133-138

  Hueber, Arno ^a   Lüke, Matthias ^a   Esser, Peter J ^a   Kirchhof, Bernd ^a   Sickel, Werner ^a   Lüke, Christoph ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; DAUNORUBICIN; FAS ANTIBODY; FAS LIGAND; OXYGEN;

AMPLITUDE MODULATION; ANIMAL TISSUE; ARTICLE; B WAVE; COW; ELECTRODE; ELECTRORETINOGRAM; NONHUMAN; PHOTORECEPTOR POTENTIAL; RETINA; VITREORETINOPATHY;

ANIMALS; CATTLE; DAUNORUBICIN; DRUG SYNERGISM; ELECTRORETINOGRAPHY; FAS LIGAND PROTEIN; MEMBRANE GLYCOPROTEINS; RETINA;

EID: 17744361855     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.133     Document Type: Article

References (22)

1. Kirmani, M., Santana, M., Sorgente, N., et al. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Retina 3:269-272, 1983.
2. Kumar, A., Tewari, H.K., Bathwal, D.P., et al. Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin. Indian J. Ophthalmol. 42:31-35, 1994.
3. Wiedemann, P., Hilgers, R.D., Bauer, P., et al. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: Results of a multicenter clinical trial. Daunomycin Study Group. Am. J. Ophthalmol. 126:550-559, 1998.
4. Kumar, A., Nainiwal, S., Choudhary, I., et al. Role of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgery. Clin. Exp. Ophthalmol. 30:348-351, 2002.
5. Laurent, G., and Jaffrezou, J.P. Signaling pathways activated by daunorubicin. Blood 98:913-924, 2001.
6. Hueber, A., Weller, M., Welsandt, G., et al. Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: Modulation by CD95L. Invest. Ophthalmol. Vis. Sci. 44:2851-2857, 2003.
7. Wang, Y.S., Hui, Y.N., and Wiedemann, P. Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells. J. Ocul. Pharmacol. Ther. 18:377-387, 2002.
8. Liang, Y.G., Jorgensen, A.G., Kaestel, G.G., et al. Bcl-2, Bax, and c-Fos expression correlates to RPE cell apoptosis induced by UV-light and daunorubicin. Curr. Eye Res. 20:25-34, 2000.
9. Shinohara, K., Tanaka, M., Sakuma, T., et al. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Ophthalmic Surg. Lasers Imaging 34:299-305, 2003.
10. Sartorius, U., Schmitz, I., and Krammer, P.H. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem 2:20-29, 2001.
11. Griffith, T.S., Brunner, T., Fletcher, S.M., et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192, 1995.
12. Mochizuki, M., Sugita, S., Ishikawa, N., et al. Immunoregulation by aqueous humor. Cornea 19:S24-S25, 2000.
13. Itoh, N., Yonehara, S., Ishii, A., et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991.
14. Hueber, A., Welsandt, G., Jordan, J.F., et al. Characterization of CD95 Ligand (CD95L)-induced apoptosis in human tenon fibroblasts. Exp. Eye Res. 75:1-8, 2002.
15. Sickel, W. Respiratory and electrical responses to light stimulation in the retina of the frog. Science 148: 648-651, 1965.
16. Lüke, C., Walter, P., Bartz-Schmidt, K.U., et al. Effects of antiviral agents on retinal function in vertebrate retina. In: Green, K., Edelhauser, H.F., Hackett, R.B., Hull, D.S., Potter, D.E., Tripathi, and R.C., eds. Advances in Ocular Toxicology, New York: Plenum Press, 107-112, 1997.
17. Furukawa, T., and Hanawa, I. Effects of some common cations on electroretinogram of the toad. Jpn. J. Physiol 5:289-300, 1955.
18. Walter, P., Lüke, C., and Sickel, W. Antibiotics and light responses in superfused bovine retina. Cell. Mol. Neurobiol. 19:87-92, 1999.
19. Santana, M., Wiedemann, P., Kirmani, M., et al. Daunomycin in the treatment of experimental proliferative vitreoretinopathy. retinal toxicity of intravitreal daunomycin in the rabbit. Graefe's Arch. Clin. Exp. Ophthalmol. 221:210-213, 1984.
20. Steinhorst, U.H., Hatchell, D.L., Chen, E.P., et al. Ocular toxicity of daunomycin: Effects of subdivided doses on the rabbit retina after vitreous gas compression. Graefe's Arch. Clin. Exp. Ophthalmol. 231: 591-594, 1993.
21. Khawly, J.A., Saloupis, P., Hatchell, D.L., et al. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 229:464-467, 1991.
22. Esser, P., Tervooren, D., Heimann, K., et al. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 39:164-170, 1998.